Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.9 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0084 | 0.9 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |